Donation represents more than 40 million international units to the WFH
By Claudia Black
WFH CEO/Executive Director
Hemophilia World, December 2009
 As part of its continued commitment to hemophilia care around the world, Wyeth, now a part of Pfizer, has pledged over 40 million international units (IUs) of factor concentrates to the World Federation of Hemophilia’s (WFH). This is the largest donation ever made to the WFH’s Humanitarian Aid Program, and will make a significant impact on advancing the WFH’s goals.
“This donation will directly support building sustainable national care programs for people with bleeding disorders,” said Mark Skinner, WFH president. “We are very proud to work with Wyeth, which has historically been the largest single donor of hemophilia products to the WFH.”
The donation will bring life-saving treatment to many people with hemophilia around the world who would not otherwise have access to adequate treatment. Notably, treatment centres and patient organizations participating in the WFH Twinning Program will receive some of the donated product which will help improve patients’ quality of life. Donations will also help support adults and young children with no access to treatment to treat life-threatening bleeding episodes.
“We are committed to working with partner organizations to provide access to hemophilia medicines to patients who need them,” said Geno Germano, president and general manager of the Specialty Care Business Unit at Pfizer.
This donation and Wyeth’s ongoing commitment will continue to strengthen the WFH’s Humanitarian Aid program and will help provide those in need with valuable, life-saving medicines.
For more information about WFH humanitarian aid contact: ahaffar@wfh.org
What is Humanitarian Aid
The WFH Humanitarian Aid Program celebrates its 10th Anniversary in 2006
Article, May 2005: ‘Donated factor saved my leg’
Last Updated January 2010 |
